Australian Real‐World Effectiveness and Safety of Ustekinumab for the Treatment of Crohn's Disease: Results of the <scp>AURORA</scp> Study, Including the <scp>ANZIBD</scp> Consortium

Yoon‐Kyo An(Mater Hospital), Jakob Begun(Translational Research Institute), Niamh Lindsay(Mater Research), Lauren S. White(Sunshine Coast University Hospital), Daniel Lightowler(The University of Western Australia), Peter De Cruz(The University of Melbourne), Anna Amiss(Mater Research), Graham Radford‐Smith(QIMR Berghofer Medical Research Institute), Rupert W. Leong(The University of Sydney), Britt Christensen(The Royal Melbourne Hospital), Kavitha Subramaniam(Australian National University), Jane M. Andrews(Health Net), Simon Ghaly(UNSW Sydney), Lena Thin(The University of Western Australia), Soong‐Yuan Ooi(Royal Brisbane and Women's Hospital), C Li Wai Suen(The University of Melbourne), Robert Gilmore(The University of Queensland), Susan J. Connor(Liverpool Hospital), Daniel R. Van Langenberg(Eastern Health), Hai Pham(QIMR Berghofer Medical Research Institute), Viraj C. Kariyawasam(Concord Repatriation General Hospital), Nikola Mitrev(Blacktown & Mount Druitt Hospital), Nik S. Ding(The University of Melbourne), Richard Fernandes(The University of Queensland), Emi Khoo(The University of Queensland), Miles Sparrow(Alfred Health), Natalie Allan(Mater Research), Robert V. Bryant(Queen Elizabeth Hospital), Astrid Williams(Liverpool Hospital), Hansjoerg Seltenreich(University of the Sunshine Coast)
JGH Open
December 1, 2025
Cited by 1


Related Papers